ELVN
Price
$21.24
Change
-$0.28 (-1.30%)
Updated
Jun 27, 12:57 PM (EDT)
Capitalization
1.27B
41 days until earnings call
VIGL
Price
$7.95
Change
-$0.00 (-0.00%)
Updated
Jun 27, 01:20 PM (EDT)
Capitalization
371.04M
46 days until earnings call
Interact to see
Advertisement

ELVN vs VIGL

Header iconELVN vs VIGL Comparison
Open Charts ELVN vs VIGLBanner chart's image
Enliven Therapeutics
Price$21.24
Change-$0.28 (-1.30%)
Volume$300
Capitalization1.27B
Vigil Neuroscience
Price$7.95
Change-$0.00 (-0.00%)
Volume$635
Capitalization371.04M
ELVN vs VIGL Comparison Chart in %
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. VIGL commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Buy and VIGL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ELVN: $21.52 vs. VIGL: $7.95)
Brand notoriety: ELVN and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 98% vs. VIGL: 29%
Market capitalization -- ELVN: $1.27B vs. VIGL: $371.04M
ELVN [@Biotechnology] is valued at $1.27B. VIGL’s [@Biotechnology] market capitalization is $371.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileVIGL’s FA Score has 0 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • VIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than VIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 5 TA indicator(s) are bullish while VIGL’s TA Score has 4 bullish TA indicator(s).

  • ELVN’s TA Score: 5 bullish, 5 bearish.
  • VIGL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than VIGL.

Price Growth

ELVN (@Biotechnology) experienced а -0.23% price change this week, while VIGL (@Biotechnology) price change was +0.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.94%. For the same industry, the average monthly price growth was +39.30%, and the average quarterly price growth was +17.54%.

Reported Earning Dates

ELVN is expected to report earnings on Aug 07, 2025.

VIGL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+9.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.27B) has a higher market cap than VIGL($371M). VIGL YTD gains are higher at: 367.647 vs. ELVN (-4.356). VIGL has higher annual earnings (EBITDA): -91.27M vs. ELVN (-109.95M). ELVN has more cash in the bank: 290M vs. VIGL (87.1M). ELVN has less debt than VIGL: ELVN (365K) vs VIGL (12.7M). ELVN (0) and VIGL (0) have equivalent revenues.
ELVNVIGLELVN / VIGL
Capitalization1.27B371M342%
EBITDA-109.95M-91.27M120%
Gain YTD-4.356367.647-1%
P/E RatioN/AN/A-
Revenue00-
Total Cash290M87.1M333%
Total Debt365K12.7M3%
TECHNICAL ANALYSIS
Technical Analysis
ELVNVIGL
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 26 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 23 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANMX159.271.64
+1.04%
Oakmark Institutional
RBCGX71.85N/A
N/A
Reynolds Blue Chip Growth
BDBKX23.62N/A
N/A
iShares Russell 2000 Small-Cap Idx K
MRIMX22.91N/A
N/A
Victory Integrity Mid-Cap Value R6
ERLGX19.08N/A
N/A
Eaton Vance Atlanta Capital Fcs Gr R6

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with DNLI. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+0.16%
DNLI - ELVN
51%
Loosely correlated
+0.28%
ERAS - ELVN
50%
Loosely correlated
-8.70%
APGE - ELVN
48%
Loosely correlated
+1.91%
SYRE - ELVN
46%
Loosely correlated
+3.96%
COGT - ELVN
46%
Loosely correlated
+3.68%
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with MRUS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then MRUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
N/A
MRUS - VIGL
49%
Loosely correlated
-1.30%
IMNN - VIGL
47%
Loosely correlated
-4.44%
OABI - VIGL
37%
Loosely correlated
+1.81%
ELVN - VIGL
36%
Loosely correlated
+0.16%
RCKT - VIGL
36%
Loosely correlated
-2.26%
More